ACTIVE

Anima Research

Export PDF

Financial year 2024 · closed on 31/12/2024

Net result

531,1 k €

-59.3% YoY

Gross margin

2 M €

-26.8% YoY

Equity

4,8 M €

+78.8% YoY

Workforce

7,0 ETP

+40.0% YoY

What does Anima Research do?

Anima Research is a Private limited company incorporated in 1994. Its main activity is: Other professional, scientific and technical activities n.e.c.. Its registered office is in Alken. It employs on average 7,0 ETP workers (FTE).

Legal situation

● Normal situation

BCE/KBO no. / VAT

BE 0452.135.608

Incorporation

05/02/1994

Legal form

Private limited company

Registered office

Alkerstraat 28
3570 Alken · FlandreSee on map

Contributed capital

1 663 500,11 €

Latest accounts

31/12/2024

Average workforce

7,0 ETP

Activities (NACE)

74909Other professional, scientific and technical activities n.e.c.· main 74999Other professional, scientific and technical activities n.e.c.85120Pre-primary education 86220Specialist medical practice activities 86220Specialist medical practice activities 71209Technical testing and analysis+3

Joint committees (1)

33004

Contacts

1 public detail availableLog in to view

Signals

ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debts

View the BCE/KBO Public Search record →

Health score

Available with a Rovalta subscriptionTry for 7 days

Recommended credit limit

✦ Verdict · Analyst summary

Financials

Trend over 17 financial years

	2024		2023		2022		2021		2018		2017		2016		2015		2014		2013		2012		2011		2010		2009		2008		2007		2006
Income statement
Gross margin	2 M €	-26.8%	2,7 M €	+152%	1,1 M €	-49.9%	2,1 M €	+957%	200,5 k €	+57.1%	127,6 k €	+6.3%	120 k €	+51.5%	79,2 k €	+116%	36,6 k €	-61.6%	95,3 k €	-44.6%	171,8 k €	+1.8%	168,9 k €	+42.2%	118,7 k €	+75.6%	67,6 k €	+47.4%	45,9 k €	-57.3%	107,5 k €	+3.2%	104,2 k €
EBITDA	1 M €	-55.2%	2,2 M €	+286%	580,6 k €	-69.9%	1,9 M €	+876%	197,9 k €	+60.4%	123,4 k €	+4.8%	117,7 k €	+108%	56,6 k €	+346%	12,7 k €	-82.0%	70,5 k €	-49.8%	140,4 k €	+2.9%	136,5 k €	+78.5%	76,5 k €	+220%	23,9 k €	+787%	-3,5 k €	-105%	74,9 k €	+143%	30,9 k €
Operating result	728,4 k €	-63.3%	2 M €	+490%	336,2 k €	-81.2%	1,8 M €	+2076%	82,2 k €	+11.2%	73,9 k €	-5.0%	77,8 k €	+382%	16,2 k €	+158%	-27,8 k €	-284%	15,1 k €	-86.3%	110,5 k €	+2.4%	107,9 k €	+182%	38,3 k €	+656%	-6,9 k €	+73.3%	-25,8 k €	-150%	51,9 k €	+330%	12,1 k €
Net result	531,1 k €	-59.3%	1,3 M €	+464%	231,4 k €	-81.6%	1,3 M €	+2260%	53,2 k €	+24.0%	42,9 k €	-21.0%	54,3 k €	+563%	-11,7 k €	+71.1%	-40,6 k €	-6493%	635,3 €	-99.2%	75,4 k €	+8.5%	69,5 k €	+199%	23,2 k €	+488%	-6 k €	+77.0%	-26 k €	-171%	36,4 k €	+456%	6,6 k €
Balance sheet
Equity	4,8 M €	+78.8%	2,7 M €	+93.2%	1,4 M €	-26.4%	1,9 M €	+377%	398,9 k €	+15.4%	345,8 k €	+14.2%	302,9 k €	+21.8%	248,6 k €	-4.5%	260,4 k €	-13.5%	301 k €	+36.7%	220,1 k €	+52.1%	144,7 k €	+92.4%	75,2 k €	+44.7%	52 k €	-10.3%	58 k €	-30.9%	84 k €	+76.7%	47,5 k €
Total assets	7,2 M €	+53.8%	4,7 M €	+2.9%	4,6 M €	-2.1%	4,7 M €	+250%	1,3 M €	+126%	590,9 k €	+0.6%	587,3 k €	+6.5%	551,6 k €	-6.5%	589,9 k €	-4.3%	616,7 k €	+32.9%	464,1 k €	+14.8%	404,3 k €	+13.5%	356,1 k €	-14.9%	418,2 k €	-0.5%	420,2 k €	+42.8%	294,2 k €	+16.5%	252,4 k €
Cash	3,6 M €	+3749%	92,7 k €	-59.4%	228,4 k €	-72.0%	814,3 k €	+1430%	53,2 k €	+2056%	2,5 k €	-17.9%	3 k €	+160%	1,2 k €	-8.9%	1,3 k €	+155%	497,5 €	-97.6%	20,7 k €	+53.2%	13,5 k €	+96.8%	6,9 k €	-62.3%	18,2 k €	+44422%	40,9 €	-99.8%	25,7 k €	-24.9%	34,3 k €
Debts	2,4 M €	+18.2%	2 M €	-36.8%	3,2 M €	+14.6%	2,8 M €	+196%	936,2 k €	+292%	238,6 k €	-15.9%	283,6 k €	-6.3%	302,6 k €	-8.1%	329,1 k €	+4.3%	315,6 k €	+29.4%	244 k €	-4.7%	256,1 k €	-8.7%	280,4 k €	-22.2%	360,3 k €	+0.4%	358,7 k €	+70.6%	210,2 k €	+12.6%	186,7 k €
Other
Workforce	7,0 ETP	+40.0%	5,0 ETP	+28.2%	3,9 ETP		–		–		–		–		0,5 ETP	0.0%	0,5 ETP	0.0%	0,5 ETP	-54.5%	1,1 ETP	-15.4%	1,3 ETP	-23.5%	1,7 ETP	-10.5%	1,9 ETP	0.0%	1,9 ETP	0.0%	1,9 ETP	0.0%	1,9 ETP

Estimate

Indicative valuation

As an indication, this company is worth

between 10 M€ and 25 M€

See the valuation

Governance

Board of directors

Seen on filing of 31/12/2024 · 5 active · 5 ended

Active mandates

Bambridge

Director · since 04 décembre 2024 · 0804.952.520

Represented by DE CLIPPEL ERIK

Active

BNP PARIBAS FORTIS PRIVATE EQUITY BELGIUM

Director · since 04 décembre 2024 · 0421.883.286

Represented by VERMEULEN SVEN

Active

EB Pharma Developments

Director · since 04 décembre 2024 · 0780.755.671

Represented by BUNTINX ERIK

Active

MAREN BUNTINX

Director · since 04 décembre 2024

Active

ERIK BUNTINX

Director · since 26 octobre 2021 · until 04 décembre 2024

Active

Ended mandates

ERIK BUNTINX

Director · since 26 octobre 2021

Ended

Erik Buntinx

Manager · since 01 juin 2015 · until 07 juin 2021

Ended

Erik Buntinx

Manager · since 26 octobre 2005

Ended

Erik Buntinx

Director

Ended

At this address

Other companies at this address

Company	CBE no.
Anima Medical● Active	1016.628.195
EB Pharma Developments● Active	0780.755.671
Elise Buntinx● Active	1004.495.376

Annual accounts

Full financial information

	2024	2023	2022	2021	2020	2019
Type of account	Abridged model	Abridged model	Abridged model	Micro model	Micro model	Micro model
Start of the financial year	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020	01/01/2019
Closing of the financial year	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020	31/12/2019
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	04/07/2025	14/08/2024	28/09/2023	04/04/2022	02/11/2021	08/10/2020
General meeting	26/06/2025	28/06/2024	21/09/2023	28/03/2022	26/10/2021	08/09/2020
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days

Filings

Annual accounts filings

19 filings with the NBB

Model	Closing	General meeting	Filed	Language	Document
Abridged model	31/12/2024	26/06/2025	04/07/2025	Dutch	PDF
Abridged model	31/12/2023	28/06/2024	14/08/2024	Dutch	PDF
Abridged model	31/12/2022	21/09/2023	28/09/2023	Dutch	PDF
Micro model	31/12/2021	28/03/2022	04/04/2022	Dutch	PDF
Micro model	31/12/2020	26/10/2021	02/11/2021	Dutch	PDF
Micro model	31/12/2019	08/09/2020	08/10/2020	Dutch	PDF
Micro model	31/12/2018	03/06/2019	30/08/2019	Dutch	PDF
Micro model	31/12/2017	04/06/2018	30/08/2018	Dutch	PDF
Micro model	31/12/2016	05/06/2017	30/08/2017	Dutch	PDF
Abridged model	31/12/2015	06/06/2016	30/08/2016	Dutch	PDF
Abridged model	31/12/2014	01/06/2015	27/08/2015	Dutch	PDF
Abridged model	31/12/2013	02/06/2014	31/07/2014	Dutch	PDF
Abridged model	31/12/2012	25/03/2013	27/08/2013	Dutch	PDF
Abridged model	31/12/2011	04/06/2012	17/07/2012	Dutch	PDF
Abridged model	31/12/2010	06/06/2011	28/06/2011	Dutch	PDF
Abridged model	31/12/2009	07/06/2010	05/08/2010	Dutch	PDF
Abridged model	31/12/2008	02/06/2009	25/08/2009	Dutch	PDF
Abridged model	31/12/2007	02/06/2008	14/08/2008	Dutch	PDF
Abridged model	31/12/2006	04/06/2007	29/08/2007	Dutch	PDF

Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 10 M€ and 25 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2024 · 5 active · 5 ended

Active mandates

Bambridge

Director · since 04 décembre 2024 · 0804.952.520

Represented by DE CLIPPEL ERIK

Active

BNP PARIBAS FORTIS PRIVATE EQUITY BELGIUM

Director · since 04 décembre 2024 · 0421.883.286

Represented by VERMEULEN SVEN

Active

EB Pharma Developments

Director · since 04 décembre 2024 · 0780.755.671

Represented by BUNTINX ERIK

Active

MAREN BUNTINX

Director · since 04 décembre 2024

Active

ERIK BUNTINX

Director · since 26 octobre 2021 · until 04 décembre 2024

Active

Ended mandates

ERIK BUNTINX

Director · since 26 octobre 2021

Ended

Erik Buntinx

Manager · since 01 juin 2015 · until 07 juin 2021

Ended

Erik Buntinx

Manager · since 26 octobre 2005

Ended

Erik Buntinx

Director

Ended

Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette

Belgian Official Gazette publications

Mandates12/05/2025
ONTSLAGEN - BENOEMINGEN
PDF
Mandates24/03/2025
ONTSLAGEN - BENOEMINGEN
PDF
Mandates06/12/2024
STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - BENAMING - ONTSLAGEN - BENOEMINGEN
PDF
Other28/11/2024
STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, )
PDF
Restructuring02/05/2022
KAPITAAL - AANDELEN - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - WIJZIGING RECHTSVORM - RUBRIEK HERSTRUCTURERING (FUSIE, SPLITSING, OVERDRACHT VERMOGEN, ENZ...)
PDF
Restructuring10/01/2022
RUBRIEK HERSTRUCTURERING (FUSIE, SPLITSING, OVERDRACHT VERMOGEN, ENZ...)
PDF
Mandates10/12/2021
ONTSLAGEN - BENOEMINGEN
PDF
Mandates18/01/2016
ONTSLAGEN - BENOEMINGEN
PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

2024
Annual accounts 2024531,1 k €↓
2024
Name changeANIMA RESEARCH
2023
Annual accounts 20231,3 M €↑
2022
Annual accounts 2022231,4 k €↓
2021
Annual accounts 20211,3 M €↑
2018
Annual accounts 201853,2 k €↑
2017
Annual accounts 201742,9 k €↓
2016
Annual accounts 201654,3 k €↑
2015
Annual accounts 2015-11,7 k €↑
2014
Annual accounts 2014-40,6 k €↓
2013
Annual accounts 2013635,3 €↓
2012
Annual accounts 201275,4 k €↑
2011
Annual accounts 201169,5 k €↑
2010
Annual accounts 201023,2 k €↑
2009
Annual accounts 2009-6 k €↑
2008
Annual accounts 2008-26 k €↓
2007
Annual accounts 200736,4 k €↑
2006
Annual accounts 20066,6 k €
2006
Name changeANIMA
05/02/1994
IncorporationPrivate limited company

10/15	1 240 000	1 180 000	1 050 000
70	8 630 000	8 120 000	7 940 000
9904	412 000	388 000	301 000
17/49	2 970 000	3 140 000	3 380 000
9087	24,3	23,1	21,8

Anima Research

Overview

What does Anima Research do?

Trend over 17 financial years

Indicative valuation

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline